These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 11208387

  • 61. Vitamin D receptor status in parathyroid adenomas.
    Sudhaker Rao D, Parfitt AM.
    J Clin Endocrinol Metab; 2001 May; 86(5):2328. PubMed ID: 11344251
    [No Abstract] [Full Text] [Related]

  • 62. The BsmI vitamin D-receptor polymorphism and secondary hyperparathyroidism.
    Schmidt S, Chudek J, Karkoszka H, Heemann U, Reichel H, Rambausek M, Kokot F, Ritz E.
    Nephrol Dial Transplant; 1997 Aug; 12(8):1771-2. PubMed ID: 9269677
    [No Abstract] [Full Text] [Related]

  • 63. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women.
    Trabert B, Malone KE, Daling JR, Doody DR, Bernstein L, Ursin G, Marchbanks PA, Strom BL, Humphrey MC, Ostrander EA.
    Breast Cancer Res; 2007 Aug; 9(6):R84. PubMed ID: 18067661
    [Abstract] [Full Text] [Related]

  • 64. Vitamin D receptor gene polymorphism and parathyroid calcium sensor protein (CAS/gp330) expression in primary hyperparathyroidism.
    Carling T, Ridefelt P, Hellman P, Juhlin C, Lundgren E, Akerström G, Rastad J.
    World J Surg; 1998 Jul; 22(7):700-6; discussion 706-7. PubMed ID: 9606285
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Vitamin D receptor (BsmI) gene polymorphism and allele frequency among chronic kidney disease patients in south Indian population.
    Badrachalam R, Mani V, Kumar R, Shafiulla A.
    Bioinformation; 2023 Jul; 19(4):380-384. PubMed ID: 37822821
    [Abstract] [Full Text] [Related]

  • 68. Analysis of CYP27B1, encoding 25-hydroxyvitamin D-1alpha-hydroxylase, as a candidate tumor suppressor gene in primary and severe secondary/tertiary hyperparathyroidism.
    Lauter K, Arnold A.
    J Bone Miner Res; 2009 Jan; 24(1):102-4. PubMed ID: 18767934
    [Abstract] [Full Text] [Related]

  • 69. Regulation of parathyroid cell proliferation.
    Silver J, Sela SB, Naveh-Many T.
    Curr Opin Nephrol Hypertens; 1997 Jul; 6(4):321-6. PubMed ID: 9263680
    [Abstract] [Full Text] [Related]

  • 70. Vitamin D receptor gene polymorphism is associated with serum total and ionized calcium concentration.
    Nakano Y, Oshima T, Sasaki S, Yamaoka K, Matsumoto T, Hirao H, Ozono R, Matsuura H, Kajiyama G, Kambe M.
    J Mol Med (Berl); 2000 Jul; 78(10):575-9. PubMed ID: 11199331
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. [Degenerated hepatic adenoma and parathyroid adenoma. Relation to hormonal treatment of polyadenomatosis].
    Messner M, Louboutin JY, Gaulier A, Lancien G, Pouliquen X, Kerdiles Y, Pawlotsky Y.
    Nouv Presse Med; 1981 Oct 03; 10(35):2904. PubMed ID: 7290944
    [No Abstract] [Full Text] [Related]

  • 74. BsmI polymorphism at the parathyroid hormone receptor locus (PTHR) in three populations.
    Hustmyer FG, Schipani E, Peacock M.
    Hum Mol Genet; 1993 Aug 03; 2(8):1330. PubMed ID: 8104630
    [No Abstract] [Full Text] [Related]

  • 75. Gender Predilection in Sporadic Parathyroid Adenomas.
    Yavropoulou MP, Anastasilakis AD, Panagiotakou A, Kassi E, Makras P.
    Int J Mol Sci; 2020 Apr 22; 21(8):. PubMed ID: 32331456
    [Abstract] [Full Text] [Related]

  • 76. Vitamin D receptors and hyperparathyroidism.
    Nagasaka S, Ishikawa S, Matoba H, Kubota K, Murakami T, Saito T.
    Nat Med; 1996 Aug 22; 2(8):834. PubMed ID: 8705842
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. BsmI vitamin D receptor polymorphism and pathogenesis of parathyroid adenoma.
    Pacheco D, Menárguez J, Cristobal E, Arribas B, Alcazar JA, Carrión R, Polo JR.
    Med Sci Monit; 2000 Aug 22; 6(4):658-60. PubMed ID: 11208387
    [Abstract] [Full Text] [Related]

  • 79. Lack of relationship between BsmI vitamin D receptor polymorphism and primary hyperparathyroidism in a Spanish female population.
    Menárguez J, Goicoechea M, Crist bal E, Arribas B, Martínez ME, Alcázar JA, Carri n R, Polo JR.
    Calcif Tissue Int; 1999 Sep 22; 65(3):214-6. PubMed ID: 10441653
    [Abstract] [Full Text] [Related]

  • 80. The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation.
    Giannini S, D'Angelo A, Nobile M, Carraro G, Rigotti P, Silva-Netto F, Pavan S, Marchini F, Zaninotto M, Dalle Carbonare L, Sartori L, Crepaldi G.
    J Bone Miner Res; 2002 Oct 22; 17(10):1768-73. PubMed ID: 12369780
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.